Country: Singapore
Language: English
Source: HSA (Health Sciences Authority)
CLOMIPRAMINE HCl
NOVARTIS (SINGAPORE) PTE LTD
N06AA04
75 mg
TABLET, FILM COATED
CLOMIPRAMINE HCl 75 mg
ORAL
Prescription Only
NOVARTIS FARMA S P A
ACTIVE
1993-10-27
ANAFRANIL Tricyclic antidepressant. Noradrenaline and preferential serotonin-reuptake inhibitor (non selective monoamine reuptake inhibitors). DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORMS Coated tablets (Anafranil ® 10, Anafranil 25) Sustained-release tablets (Anafranil SR 75) Sustained-release tablets, divisible (Anafranil SR 75 Divitabs) Capsules Information might differ in some countries. ACTIVE SUBSTANCE The active ingredient is 3-Chloro-5-[3-(dimethylamino)-propyl] 10, 11-dihydro-5H-dibenz- [b,f]azepine hydrochloride (clomipramine hydrochloride). One coated tablet contains 10 mg or 25 mg clomipramine hydrochloride. One sustained-release tablet (divisible and non-divisible) contains 75 mg clomipramine hydrochloride. One capsule contains 10 mg, 25 mg or 50 mg clomipramine hydrochloride. ACTIVE MOIETY Clomipramine Certain dosage strengths and dosage forms may not be available in all countries. EXCIPIENTS 10 mg and 25 mg Coated tablets: Lactose monohydrate, Maize starch, Hypromellose (hydroxypropyl methylcellulose), Magnesium stearate, Silica colloidal anhydrous, Talc, Copovidone (vinylpyrrolidone/vinylacetate copolymer), Titanium dioxide (E171), Sucrose, Povidone (polyvinylpyrrolidone), Iron oxide, yellow (E172), Macrogol 8000 (polyethylene glycol 8000), Cellulose microcrystalline. The 25 mg Coated tablets also contain Stearic acid and Glycerol (85%). Sustained-release, divisible tablets: Calcium hydrogen phosphate dihydrate, Polyacrylate dispersion 30%, Calcium stearate, Silica colloidal anhydrous, Hypromellose (hydroxypropyl methylcellulose), Talc, Titanium dioxide, Macrogolglycerol hydroxystearate (polyoxyl 40 hydrogenated castor oil), Iron oxide red. No Read the complete document
ANAFRANIL Tricyclic antidepressant. Noradrenaline and preferential serotonin-reuptake inhibitor (nonselective monoamine reuptake inhibitors). DESCRIPTION AND COMPOSITION PHARMACEUTICAL FORMS Coated tablets (Anafranil 10mg, Anafranil 25mg) Sustained-release tablets (Anafranil SR 75mg) Sustained-release tablets, divisible (Anafranil SR 75mg Divitabs) Capsules Information might differ in some countries. ACTIVE SUBSTANCE The active ingredient is 3-Chloro-5-[3-(dimethylamino)-propyl] 10, 11-dihydro-5H-dibenz- [b,f]azepine hydrochloride (clomipramine hydrochloride). One coated tablet contains 10 mg or 25 mg of clomipramine hydrochloride. One sustained-release tablet (divisible and non-divisible) contains 75 mg clomipramine hydrochloride. One capsule contains 10 mg, 25 mg or 50 mg clomipramine hydrochloride. ACTIVE MOIETY Clomipramine Certain dosage strengths and dosage forms may not be available in all countries. EXCIPIENTS 10 mg and 25 mg Coated tablets: Lactose monohydrate, Maize starch, Hypromellose (hydroxypropyl methylcellulose), Magnesium stearate, Silica colloidal anhydrous, Talc, Copovidone (vinylpyrrolidone/vinylacetate copolymer), Titanium dioxide (E171), Sucrose, Povidone (polyvinylpyrrolidone), Iron oxide, yellow (E172), macrogol 8000 (polyethylene glycol 8000), Cellulose microcrystalline. The 25 mg Coated tablets also contain Stearic acid and Glycerol (85%). Sustained-release, divisible tablets: Calcium hydrogen phosphate dihydrate, Polyacrylate dispersion 30%, Calcium stearate, Silica colloidal anhydrous, Hypromellose (hydroxypropyl methylcellulose), Talc, Titanium dioxide, Macrogolglycerol hydroxystearate (polyoxyl 40 hydrogenated castor oil), Iron oxide red. Novartis Page 2 Country Specific Package Leaflet 03 Jan 2015 Anafranil Tablets Sustained-release tablets (non-divisible) and capsules: excipients country-specific. Pharmaceutical formulations may vary between countries. INDICATIONS ADULTS Treatment of depressive states of varying aetiology and symptomatology, e.g. endogenous, reactive, neuro Read the complete document